4-(2,4,5-trimethoxyphenyl)-4-oxobutyric acid, 95.0%, 5g

Solución de tetracloroplatinato(II) de sodio 50 g

(6S)-Hexahydro-1,4-oxazepin-6-ol, 98%, 100mg

3-(4-CHLORO-1H-INDOL-1-YL)PROPAN-1-AMINE HCL, 95.0%, 250mg

Methyl 2-(3-formylphenoxy)acetate, 95+%, 5g

(S)-methyl 5-((S)-1,1-dimethylethylsulfinamido)-5-(4-morpholinophenyl)-3-oxo-5-(thiophen-3-yl)pentanoate, 97%, 10mg

(S)-tert-Butyl 2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate, 95.0%, 25g

(3R,4R)-tert-Butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate, 95.0%, 1g

1,2,3,4-Tetrahydro-benzo[b]azepin-5-one, 97.0%, 100g

2,2'-Bipyridine-5-carboxylic acid, 97.0%, 250mg

Ruthenium(III) iodide, anhydrous, 97%, 5g

Adenosina-CPG-Soporte

N-?[(11bS)?-?2,?6-?Bis[3,?5-?bis(trifluoromethyl)?phenyl]?-?4-?oxido-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?yl]?-?1,?1,?1-?trifluoromethanesulfonamide, 97%, 1g